| Acute exacerbations of idiopathic pulmonary fibrosis HR Collard, BB Moore, KR Flaherty, KK Brown, RJ Kaner, TE King Jr, ... American journal of respiratory and critical care medicine 176 (7), 636-643, 2007 | 1356 | 2007 |
| An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features A Fischer, KM Antoniou, KK Brown, J Cadranel, TJ Corte, RM Du Bois, ... European Respiratory Journal 46 (4), 976-987, 2015 | 933 | 2015 |
| Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study I Noth, Y Zhang, SF Ma, C Flores, M Barber, Y Huang, SM Broderick, ... The Lancet respiratory medicine 1 (4), 309-317, 2013 | 609 | 2013 |
| Churg-strauss syndrome I Noth, ME Strek, AR Leff The Lancet 361 (9357), 587-594, 2003 | 551 | 2003 |
| A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis I Noth, KJ Anstrom, SB Calvert, J De Andrade, KR Flaherty, C Glazer, ... American journal of respiratory and critical care medicine 186 (1), 88-95, 2012 | 550 | 2012 |
| Association between telomere length and risk of cancer and non-neoplastic diseases: a Mendelian randomization study PC Haycock, S Burgess, A Nounu, J Zheng, GN Okoli, J Bowden, ... JAMA oncology 3 (5), 636-651, 2017 | 501 | 2017 |
| Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis AL Peljto, Y Zhang, TE Fingerlin, SF Ma, JGN Garcia, TJ Richards, ... Jama 309 (21), 2232-2239, 2013 | 495 | 2013 |
| Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials JS Lee, HR Collard, KJ Anstrom, FJ Martinez, I Noth, RS Roberts, E Yow, ... The Lancet Respiratory Medicine 1 (5), 369-376, 2013 | 450 | 2013 |
| Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study MLK Han, Y Zhou, S Murray, N Tayob, I Noth, VN Lama, BB Moore, ... The Lancet Respiratory Medicine 2 (7), 548-556, 2014 | 389 | 2014 |
| TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis JM Oldham, SF Ma, FJ Martinez, KJ Anstrom, G Raghu, DA Schwartz, ... American journal of respiratory and critical care medicine 192 (12), 1475-1482, 2015 | 331 | 2015 |
| Autoimmune-featured interstitial lung disease: a distinct entity R Vij, I Noth, ME Strek Chest 140 (5), 1292-1299, 2011 | 323 | 2011 |
| Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosis JD Herazo-Maya, I Noth, SR Duncan, SH Kim, SF Ma, GC Tseng, ... Science translational medicine 5 (205), 205ra136-205ra136, 2013 | 303 | 2013 |
| Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation BD Stuart, JS Lee, J Kozlitina, I Noth, MS Devine, CS Glazer, F Torres, ... The lancet Respiratory medicine 2 (7), 557-565, 2014 | 291 | 2014 |
| Characterisation of patients with interstitial pneumonia with autoimmune features JM Oldham, A Adegunsoye, E Valenzi, C Lee, L Witt, L Chen, AN Husain, ... European Respiratory Journal 47 (6), 1767-1775, 2016 | 285 | 2016 |
| Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study RJ Allen, J Porte, R Braybrooke, C Flores, TE Fingerlin, JM Oldham, ... The Lancet respiratory medicine 5 (11), 869-880, 2017 | 271 | 2017 |
| PD-1 up-regulation on CD4+ T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production LJ Celada, JA Kropski, JD Herazo-Maya, W Luo, A Creecy, AT Abad, ... Science translational medicine 10 (460), eaar8356, 2018 | 269 | 2018 |
| Genome-wide association study of susceptibility to idiopathic pulmonary fibrosis RJ Allen, B Guillen-Guio, JM Oldham, SF Ma, A Dressen, ML Paynton, ... American journal of respiratory and critical care medicine 201 (5), 564-574, 2020 | 259 | 2020 |
| Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report TS Blackwell, AM Tager, Z Borok, BB Moore, DA Schwartz, KJ Anstrom, ... American journal of respiratory and critical care medicine 189 (2), 214-222, 2014 | 249 | 2014 |
| A Variant in the Promoter of MUC5B and Idiopathic Pulmonary Fibrosis Y Zhang, I Noth, JGN Garcia, N Kaminski New England Journal of Medicine 364 (16), 1576-1577, 2011 | 234 | 2011 |
| ERS/ATS task force on undifferentiated forms of CTD-ILD A Fischer, KM Antoniou, KK Brown, J Cadranel, TJ Corte, RM Du Bois, ... An official European respiratory society/American thoracic society research …, 2015 | 158 | 2015 |
